Xconomy’s Digital Events →
Propeller Health received FDA clearance to market two new medication-tracking devices that attach to the Respimat (left) and Diskus (right) inhalers. Photo courtesy of Propeller Health.
From Our Editors · Podcast
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.